» » Extended Tumor Control After Dendritic Cell Vaccination With Low Dose Cyclophosphamide as Adjuvant Treatment in Patients With Malignant Pleural Mesothelioma.

0
CONCLUSIONS: Consolidation therapy with autologous tumor lysate-pulsed dendritic cell-based therapy and simultaneously reducing the tumor-induced immune suppression is well-tolerated, and shows signs of clinical activity in mesothelioma patients. Clinical trial registration available at www.clinicaltrials.gov, ID NCT01241682. PMID: 26652184 [PubMed - as supplied by publisher] (Source: American Journal of Respiratory and Critical Care Medicine)

from MedWorm: Mesothelioma http://www.medworm.com/index.php?rid=158964942&cid=c_409_40_f&fid=36889&url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmed%2F26652184%3Fdopt%3DAbstract
ad

Share to:

Enregistrer un commentaire

Emoticon
:) :)) ;(( :-) =)) ;( ;-( :d :-d @-) :p :o :>) (o) [-( :-? (p) :-s (m) 8-) :-t :-b b-( :-# =p~ $-) (b) (f) x-) (k) (h) (c) cheer
Click to see the code!
To insert emoticon you must added at least one space before the code.

Inscription à : Publier les commentaires (Atom)
 
Top